Clinical studyPercutaneous Femoral Implantation of an Arterial Port Catheter for Intraarterial Chemotherapy: Feasibility and Predictive Factors of Long-term Functionality
Section snippets
Materials and Methods
Data from a series of 93 consecutive patients who underwent percutaneous implantation of an arterial port catheter in our hospital from November 2001 to May 2008 were retrospectively analyzed.
Catheter Implantation
The overall technical success rate of catheter implantation was 98% (n = 91 of 93).
Discussion
Advances in minimally invasive techniques have allowed the percutaneous femoral implantation of a catheter for intraarterial chemotherapy under local anesthesia. The catheter implantation success rate has been reported to be 90%–100% in the literature (8, 9, 10, 11, 12, 13).
In our experience, failure of percutaneous implantation occurred in only two cases (2%), including one that could not be overcome by surgical placement. Our experience indicates that today when intraarterial chemotherapy is
References (22)
- et al.
Interventional techniques for hepatic arterial infusion chemotherapy
Tech Vasc Interv Radiol
(2007) - et al.
Society of Interventional Radiology clinical practice guidelines
J Vasc Interv Radiol
(2003) - et al.
Efficacy and safety of hepatic artery infusion catheter placement without fixation in the right gastroepiploic artery
J Vasc Interv Radiol
(2005) - et al.
Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy
J Vasc Interv Radiol
(2003) Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modified fixed catheter tip technique
J Vasc Interv Radiol
(2001)- et al.
Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy
J Vasc Interv Radiol
(1998) - et al.
Catheter redundancy in the aortic arch increases the risk of stroke in left subclavian arterial port-catheter systems
J Vasc Interv Radiol
(2005) - et al.
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
J Clin Oncol
(2008) - et al.
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
J Clin Oncol
(2005) - et al.
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
N Engl J Med
(2004)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200
J Clin Oncol
Cited by (54)
Transradial versus Transfemoral Access for Patients with Liver Cancer Undergoing Hepatic Arterial Infusion Chemotherapy: Patient Experience and Procedural Complications
2022, Journal of Vascular and Interventional RadiologyCitation Excerpt :A recent study (20) reported that operators needed to perform ≥20 procedures to achieve high levels of proficiency during TRA catheterizations in patients with liver cancer undergoing chemoembolization. Catheter-related adverse events of HAIC have been reported, including gastroduodenal ulceration, catheter infection, migration, and occlusion, with an incidence ranging from 31% to 52% (21–23). Catheter migration and disconnection contribute to extrahepatic administration of chemotherapeutic drugs, adversely affecting treatment efficacy (24).
The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment
2022, Revista de Gastroenterologia de MexicoHepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study
2017, Clinical Colorectal Cancer
None of the authors have identified a conflict of interest.